Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prospective OCEAN-TAVI registry in Japan

OBJECTIVES: The aim of this study was to investigate the 2-year prognostic impact of N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels at discharge following transcatheter aortic valve implantation (TAVI). DESIGN: Multicentre prospective observational study. SETTINGS: Seven institutions f...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizutani, Kazuki, Hara, Masahiko, Nakao, Mana, Okai, Tsukasa, Kajio, Keiko, Murakami, Takashi, Shibata, Toshihiko, Yoshiyama, Minoru, Naganuma, Toru, Yamanaka, Futoshi, Higashimori, Akihiro, Tada, Norio, Takagi, Kensuke, Araki, Motoharu, Ueno, Hiroshi, Tabata, Minoru, Shirai, Shinichi, Watanabe, Yusuke, Yamamoto, Masanori, Hayashida, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104765/
https://www.ncbi.nlm.nih.gov/pubmed/30121598
http://dx.doi.org/10.1136/bmjopen-2017-021468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104765/
https://www.ncbi.nlm.nih.gov/pubmed/30121598
http://dx.doi.org/10.1136/bmjopen-2017-021468

Ejemplares similares